EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties

Daniil S Abramchuk iD, Olga O Krasnovskaya iD, Alevtina S Voskresenskaya iD, Alexander N Vaneev iD, Regina M Kuanaeva iD, Vugara V Mamed-Nabizade iD, Vasilii S Kolmogorov iD, Olga I Kechko, Vladimir A Mitkevich iD, Alexander A Makarov iD, Alexei A Nastenko iD, Maxim A Abakumov iD und 4 weitere

International Journal of Molecular Sciences · 09.12.2025 · 26 (24) · 11876

DOI: 10.3390/ijms262411876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.12.2025. Verfasst von Daniil S Abramchuk und 15 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1,3, 119991 Moscow, Russia. Hauptthemen laut MEDLINE: Clioquinol, Boron Compounds, Copper, Chelating Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation, Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a worldwide problem due to the lack of effective therapy and accurate methods for timely diagnosis. The complexity of AD’s pathophysiology complicates the development of effective therapeutic agents, as most drugs act on only one therapeutic target, bypassing others. The design and development of multifunctional agents capable of altering metal ion-induced abnormalities, oxidative stress, and toxic beta amyloid (Aβ) aggregates is of interest. Herein, we report the first boron dipyrromethene (BODIPY) based bifunctional copper chelator with clioquinol, BDP-CLQ, capable of both optical detection of Aβ fibrils and copper chelation, with multiple anti-AD properties. Foremost, BDP-CLQ demonstrated a 3-fold and 5-fold fluorescence increase at 650 nm and 565 nm in the presence of Aβ and effective copper chelation (pKd = 16.6 ± 0.3). In addition, BDP-CLQ demonstrated a potent inhibition of Aβ aggregation, reduction in Aβ-induced stiffness of neuronal cells, and antioxidant activity. BDP-CLQ is the first BODIPY-based fluorescent probe with multiple anti-AD activities, as well as the first clioquinol-based probe capable of Aβ optical visualization. This study demonstrates the prospects of the development of clioquinol-based theranostic probes since this allows combining several promising anti-AD actions in a single molecule and developing multi-targeted drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClioquinolBoron CompoundsCopperChelating AgentsAlzheimer DiseaseAmyloid beta-PeptidesHumansFluorescent DyesAnimalsAntioxidants

Stichwörter der Autor:innen

Alzheimer’s disease (AD)amyloid beta (Aβ)boron dipyrromethene (BODIPY)clioquinolcopper chelatoroptical visualizationscanning ion conductance microscopy (SICM)

Substanzen

ClioquinolBoron CompoundsCopperChelating Agents4,4-difluoro-4-bora-3a,4a-diaza-s-indaceneAmyloid beta-PeptidesFluorescent DyesAntioxidants

Autor:innen und Institutionen

  • Chemistry Department, Lomonosov Moscow State University, Leninskie Gory 1,3, 119991 Moscow, Russia.
  • Laboratory of Biophysics, National University of Science and Technology (MISIS), Leninskiy Prospect 4, 119049 Moscow, Russia.
  • Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Vavilov Str. 32, 117292 Moscow, Russia.
  • Department of Medical Nanobiotechnology, N.I. Pirogov Russian National Research Medical University, Ostrovityanova Str., 1, 6, 117997 Moscow, Russia.

ORCID-Profile: Daniil S Abramchuk, Olga O Krasnovskaya, Alevtina S Voskresenskaya, Alexander N Vaneev, Regina M Kuanaeva, Vugara V Mamed-Nabizade, Vasilii S Kolmogorov, Vladimir A Mitkevich, Alexander A Makarov, Alexei A Nastenko, Maxim A Abakumov, Petr V Gorelkin, Elena K Beloglazkina, Alexander S Erofeev

Förderung

  • Russian Science Foundation
  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Abramchuk, D. S., Krasnovskaya, O. O., Voskresenskaya, A. S., Vaneev, A. N., Kuanaeva, R. M., Mamed-Nabizade, V. V., Kolmogorov, V. S., Kechko, O. I., Mitkevich, V. A., Makarov, A. A., Nastenko, A. A., Abakumov, M. A., Gorelkin, P. V., Salikhov, S. V., Beloglazkina, E. K., & Erofeev, A. S. (2025). Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties. International Journal of Molecular Sciences, 26(24), 11876. https://doi.org/10.3390/ijms262411876

Vancouver

Abramchuk DS, Krasnovskaya OO, Voskresenskaya AS, Vaneev AN, Kuanaeva RM, Mamed-Nabizade VV, et al. Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties. International Journal of Molecular Sciences. 2025;26(24):11876. doi:10.3390/ijms262411876

BibTeX
@article{Abramchuk2025,
  author = {Abramchuk, Daniil S and Krasnovskaya, Olga O and Voskresenskaya, Alevtina S and Vaneev, Alexander N and Kuanaeva, Regina M and Mamed-Nabizade, Vugara V and Kolmogorov, Vasilii S and Kechko, Olga I and Mitkevich, Vladimir A and Makarov, Alexander A and Nastenko, Alexei A and Abakumov, Maxim A and Gorelkin, Petr V and Salikhov, Sergei V and Beloglazkina, Elena K and Erofeev, Alexander S},
  title = {Bifunctional BODIPY-Clioquinol Copper Chelator with Multiple Anti-AD Properties},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {11876},
  doi = {10.3390/ijms262411876}
}
Kostenlos starten →